sardocorcorp.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Programs | Medera
Description Clinical Sardocor, a subsidiary wholly-owned by Medera, is dedicated to the clinical development of novel therapies for patients with incurable diseases.Building upon Novoheart’s bioengineered human-specific assays for disease modelling and drug discovery,
Keywords N/A
Server Information
WebSite sardocorcorp faviconsardocorcorp.com
Host IP 142.4.5.211
Location United States
Related Websites
Site Rank
More to Explore
sardocorcorp.com Valuation
US$1,194
Last updated: 2023-05-07 05:33:53

sardocorcorp.com has Semrush global rank of 0. sardocorcorp.com has an estimated worth of US$ 1,194, based on its estimated Ads revenue. sardocorcorp.com receives approximately 137 unique visitors each day. Its web server is located in United States, with IP address 142.4.5.211. According to SiteAdvisor, sardocorcorp.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,194
Daily Ads Revenue US$1
Monthly Ads Revenue US$33
Yearly Ads Revenue US$396
Daily Unique Visitors 9
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
sardocorcorp.com. A 599 IP: 142.4.5.211
sardocorcorp.com. NS 3600 NS Record: ns40.domaincontrol.com.
sardocorcorp.com. NS 3600 NS Record: ns39.domaincontrol.com.
sardocorcorp.com. MX 3600 MX Record: 0 sardocorcorp-com.mail.protection.outlook.com.
sardocorcorp.com. TXT 3600 TXT Record: MS=ms30939143
sardocorcorp.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-07 05:33:53
Menu Home About Us Vision Mission and Objectives Key Milestones Management Team External Advisors Scientific Advisory Board Platform Novoheart mini-Life Platform mini-Organs Products Instrumentation Programs Sardocor Pipeline Our Targeted Organ Systems Medical White Paper Responsibility Safety of Patients Employees Environmental and Social Corporate Governance Community and Giving Newsroom Press Releases Media Coverage Partnership Careers Contact Us Clinical Programs Sardocor, Medera’s subsidiary, is dedicated to the clinical development of novel therapies for patients with incurable diseases. Building upon Novoheart’s bioengineered human tissue-based assays for disease modelling and drug discovery, Sardocor aspires to create the shortest regulatory path to the clinic for advancing effective next-generation cell & gene therapy. Pipeline Medera’s Sardocor has 15 pre-clinical and 10 clinical programs in the pipeline. With the mini-Life Platform, the total number of novel pre-clinical
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 10:31:44 GMT
Server: Apache
X-Redirect-By: WordPress
Location: http://www.sardocorcorp.com/
Vary: User-Agent
Content-Type: text/html; charset=UTF-8

HTTP/1.1 200 OK
Date: Wed, 27 Oct 2021 10:31:45 GMT
Server: Apache
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Vary: User-Agent
Content-Type: text/html; charset=UTF-8
sardocorcorp.com Whois Information
Domain Name: SARDOCORCORP.COM
Registry Domain ID: 2546636539_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-07-17T08:22:32Z
Creation Date: 2020-07-17T08:22:32Z
Registry Expiry Date: 2025-07-17T08:22:32Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS39.DOMAINCONTROL.COM
Name Server: NS40.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T08:01:59Z <<<